PULSE: Intravenous Pentamidine for Pneumocystis jiroveci Pneumonia Prophylaxis in Adult Cancer Patients Undergoing Intensive Chemotherapy Regimens
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Target Audience
Pharmacist
Learning Objectives
- Identify current guideline recommendations and agents used for Pneumocystis jiroveci pneumonia prophylaxis during intensive chemotherapy in cancer patients.
- Discuss advantages and disadvantages of IV pentamidine for use as Pneumocystis jiroveci pneumonia prophylaxis.
- Discuss the literature supporting IV pentamidine use in the adult population and it’s place in therapy for Pneumocystis jiroveci pneumonia prophylaxis during intensive chemotherapy in cancer patients.
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Autumn Smith, PharmD
PGY1 Pharmacy Resident
UPMC Presbyterian
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.